StockData
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. (CMMB) income statement

CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 5/30
$1.19+0.05 (+4.39%)

Close on Nov 20, 2026Market cap $8.56MP/E 0.8Yield –

See a number that looks wrong?